Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Fuji
Covington
Harvard Business School
Express Scripts
Cantor Fitzgerald

Generated: July 22, 2019

DrugPatentWatch Database Preview

Patent: 9,404,087

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,404,087
Title:Insulin producing cells derived from pluripotent stem cells
Abstract: A method of generating islet cells from pluripotent stem cells is disclosed. The method comprises: (a) culturing the pluripotent stem cells in a differentiation medium so as to differentiate the pluripotent stem cells into endoderm cells; and (b) culturing the endoderm cells in a medium comprising at least one growth factor, a cAMP inducer and retinoic acid (RA), said at least one growth factor being selected from the group consisting of FGF10, bFGF and FGF7 so as to generate further differentiated cells; and (c) culturing the further differentiated cells in a medium comprising a maturation factor selected from the group consisting of nicotinamide, GLP-1 and exendin 4, thereby generating islet cells from pluripotent stem cells. Further methods of generating islet cells are also disclosed, isolated cell populations comprising same and uses thereof.
Inventor(s): Revel; Michel (Rehovot, IL), Chebath; Judith (Rehovot, IL), Slutsky; Guy (Holon, IL), Levy; Alon (Ramat-HaSharon, IL), Izrael; Michal (Rehovot, IL), Hasson; Arik (Kiryat-Ono, IL), Molakandov; Kfir (Yahud, IL), Kaufman; Rosalia (Rehovot, IL)
Assignee: Kadimastem Ltd. (Nes-Ziona, IL)
Application Number:13/989,805
Patent Claims:see list of patent claims

Details for Patent 9,404,087

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04 ➤ Try a Free Trial Kadimastem Ltd. (Nes-Ziona, IL) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Julphar
Baxter
Chubb
Teva
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.